Central Pain Study for ABX-1431

Clinical trial NCT03138421 · COMPLETED

Trial details

NCT number: NCT03138421
Sponsor: Abide Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorder Transverse Myelitis Multiple Sclerosis Longitudinally Extensive Transverse Myelitis

Start date: 2017-08-01
Primary completion: 2018-07-23
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.